Cetera Investment Advisers’s Dogwood Therapeutics DWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-423
Closed -$1.8K 3913
2024
Q3
$1.8K Sell
423
-53
-11% -$275 ﹤0.01% 3697
2024
Q2
$2.56K Sell
476
-8
-2% -$69 ﹤0.01% 3696
2024
Q1
$5.8K Buy
+484
New +$5.43K ﹤0.01% 3664
2023
Q2
Sell
-1,071
Closed -$9.84K 2316
2023
Q1
$9.84K Buy
1,071
+425
+66% +$3.38K ﹤0.01% 2139
2022
Q4
$3.81K Buy
+646
New +$4.87K ﹤0.01% 2092

Other funds holding DWTX

Cetera Investment Advisers's DWTX Position: Q4 2024 in Review

Cetera Investment Advisers sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 423 shares — an estimated $1.8K sold.

Cetera Investment Advisers first reported a position in DWTX in Q4 2022 and held it in 5 quarters. The position peaked at $9.84K in Q1 2023. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • Cetera Investment Advisers reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 423 Dogwood Therapeutics shares in Q4 2024, an estimated $1.8K.
  • Cetera Investment Advisers first reported a position in Dogwood Therapeutics in Q4 2022 and held it in 5 quarters.
  • Cetera Investment Advisers's Dogwood Therapeutics position peaked at $9.84K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on Cetera Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.